Medicinal Products

EFFERALGANTAB 1 g

Generic drug of the therapeutic class: Analgesics
active ingredients: Paracetamol
laboratory: Bristol Myers Squibb

Coated tablet
Box of 8
All forms

Indication

Symptomatic treatment of mild to moderate pain and / or febrile conditions.

Dosage EFFERALGANTAB 1 g Film-coated tablet Box of 8

Administration mode

Oral way.

The tablets are swallowed as is with a drink (eg water, milk, fruit juice).

Dosage

This presentation is RESERVED ADULT and CHILD from 50 kg (from about 15 years).

The usual dosage is 1 tablet to 1 g per dose, to be renewed if necessary after 4 hours minimum.

It is generally not necessary to exceed 3 g of paracetamol per day, or 3 tablets .

However, in case of more severe pain, the maximum dosage can be increased up to 4 g per day, or 4 tablets per day.

Always respect an interval of 4 hours between catches.

Maximum recommended doses: see section Warnings and precautions for use .

Frequency of administration

Systematic catches prevent pain or fever oscillations:

· In adults, they must be spaced at least 4 hours apart.

Renal failure:

In cases of severe renal impairment (creatinine clearance less than 10 ml / min), the interval between two doses should be increased to at least 8 hours. The dose of paracetamol should not exceed 3 g per day, or 3 tablets.

The lowest effective daily dose should be considered, not exceeding 60 mg / kg / day (not to exceed 3 g / day) under the following conditions:

· Adults under 50 kg,

· Mild to moderate hepatocellular insufficiency,

· Chronic alcoholism,

· Chronic malnutrition,

· Dehydration.

Against indications

· Hypersensitivity to paracetamol or other components.

· Hepatocellular insufficiency.

Adverse effects Efferalgantab

· A few rare cases of hypersensitivity reactions such as anaphylactic shock, angioedema, erythema, urticaria, skin rash have been reported. Their occurrence requires the definitive discontinuation of this drug and related drugs.

· Very exceptional cases of thrombocytopenia, leukopenia and neutropenia have been reported.

Popular Posts

Category Medicinal Products, Next Article